Position in ANNX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$501,297
-$89,898 QoQ
Shares Held
90,487
-23.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026J. Safra Sarasin Holding AG holds $32,968,666 across 16 Biotechnology names. ANNX ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
93,181 | $15,236,957 | |
| 2 | INCY |
Incyte Corp
|
30,341 | $2,855,694 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
43,719 | $2,469,686 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
21,001 | $2,042,347 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,195 | $1,873,235 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
73,058 | $1,429,014 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,323 | $1,216,020 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,230 | $1,068,710 |
All Filings in ANNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $501,297 | 90,487 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $591,195 | 117,768 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $680,824 | 223,221 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $915,458 | 381,441 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $491,258 | 254,538 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $798,966 | 155,744 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||